319 results on '"Fan, Jinhai"'
Search Results
2. Association between oxidative balance score and kidney stones: data from the national health and nutrition examination survey (NHANES)
3. CACA guidelines for holistic integrative management of urothelial carcinoma
4. Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis
5. PAQR5 inhibits the growth and metastasis of clear cell renal cell carcinoma by suppressing the JAK/STAT3 signaling pathway
6. The photothermal effect induces M1 macrophage-derived TNF-α-type exosomes to inhibit bladder tumor growth
7. Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation
8. NEIL3 promotes cell proliferation of ccRCC via the cyclin D1-Rb-E2F1 feedback loop regulation
9. Recent advances of cellulose nanofiber-based materials in cell culture: From population to single-cell
10. Automatic-degradable Mo-doped W18O49 based nanotheranostics for CT/FL imaging guided synergistic chemo/photothermal/chemodynamic therapy
11. Inhibition of autophagy can promote the apoptosis of bladder cancer cells induced by SC66 through the endoplasmic reticulum stress pathway
12. Diagnostic accuracy of cystoscopic biopsy for tumour grade in outpatients with urothelial carcinoma of the bladder and the risk factors of upgrading
13. Association of gallstone and polymorphisms of UGT1A1*27 and UGT1A1*28 in patients with hepatitis B virus-related liver failure
14. MP18-17 ARGININE-RICH PEPTIDE CONJUGATES ENHANCE TUMOR-TARGETED IMAGING AND DELIVERY MEDIATED BY THE PIEZO1/INTEGRIN β1 AXIS IN BLADDER CANCER
15. Multiplex ratiometric gold nanoprobes based on surface-enhanced Raman scattering enable accurate molecular detection and imaging of bladder cancer
16. R11 peptides can promote the molecular imaging of spherical nucleic acids for bladder cancer margin identification
17. Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation
18. Expression of collagen type ? alpha 4 chain in clear cell renal cell carcinoma and its relationship with prognosis and immune infi ltration.
19. Modified wet chemical method synthesis of nano-ZrO2 and its application in preparing membranes
20. Survival after radical cystectomy for bladder cancer: Multicenter comparison between minimally invasive and open approaches
21. Table S1-S8 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
22. Figure S1-S6 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
23. Data from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
24. Supplementary Information 1 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
25. ITPR3 facilitates tumor growth, metastasis and stemness by inducing the NF-ĸB/CD44 pathway in urinary bladder carcinoma
26. Knockdown of CXCL5 inhibits the invasion, metastasis and stemness of bladder cancer lung metastatic cells by downregulating CD44
27. En bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer
28. Green-laser assisted laparoscopic partial cystectomy for selective muscle-invasive bladder cancer: technique and initial outcome
29. Global, regional, and national levels and trends in burden of urticaria: a systematic analysis for the global burden of disease 2019 study
30. Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
31. A novel 450-nm blue laser system for surgical applications: efficacy of specific laser-tissue interactions in bladder soft tissue
32. MDR3 rs2109505 and rs1202283 polymorphisms are associated with susceptibility to intrahepatic cholestasis of pregnancy: A meta-analysis
33. Melt-based embedded printing for freeform fabrication of overhanging and flexible polycaprolactone scaffolds
34. NEIL3 promotes the proliferation of ccRCC via the cyclin D1-Rb-E2F1 feedback loop regulation
35. Biological Properties of Arginine-rich Peptides and their Application in Cargo Delivery to Cancer
36. MP63-18 UriFIND ASSAY FACILITATES WHOLE COURSE MANAGEMENT OF UROTHELIAL CARCINOMA IN A LARGE MULTICENTRIC, PROSPECTIVE CHINA COHORT
37. MUC15 inhibits cancer metastasis via PI3K/AKT signaling in renal cell carcinoma
38. Supplemental Figure 3 from Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03
39. Supplemental Figure 1 from Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03
40. Supplemental Table 1-3 from Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03
41. Supplementary Figures S1-S3 from Effect of Trans-2,3-Dimethoxycinnamoyl Azide on Enhancing Antitumor Activity of Romidepsin on Human Bladder Cancer
42. Supplemental Figure 2 from Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03
43. Supplementary Figures 1-2 from Inhibition of Mitogen-Elicited Signal Transduction and Growth in Prostate Cancer with a Small Peptide Derived from the Functional Domain of DOC-2/DAB2 Delivered by a Unique Vehicle
44. Efficacy and safety of a novel 450 nm blue diode laser versus plasmakinetic electrocautery for the transurethral resection of non-muscle invasive bladder cancer: The protocol and result of a multicenter randomized controlled trial
45. Additional file 3 of Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation
46. Additional file 2 of Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation
47. Combination of Two T1 Substaging Systems (T1a/b/c and T1m/e) Better Predicts Tumor Outcomes in Patients with T1 High Grade Bladder Cancer
48. Potential Mechanisms of Osthole against Bladder Cancer Based on Network Pharmacology, Molecular Docking, and Experimental Validation
49. Identification of Biomarkers Related to Tumor Associated Macrophages in Clear Cell Renal Cell Carcinoma with Weighted gene co-expression network analysis
50. Identification of a six-gene prognostic signature for bladder cancer associated macrophage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.